Arrhythmia treatment cost in China depends on the required intervention, with radiofrequency ablation ranging from $6,500 to $11,000 and radiofrequency ablation with 3D mapping running $8,500 to $17,000. Total expenses depend on the choice between cryoablation or radiofrequency methods, device types, and clinic tier. Patients typically save 40-60% compared to the US. Top treatment hubs include Hangzhou, Xiamen, and Haikou.
Typical Arrhythmia Treatment Costs in China
Bookimed Expert Insight: Complex cases requiring high precision benefit from centers like Sir Run Run Shaw Hospital (SRRSH). As a JCI-accredited Mayo Clinic Care Network member, SRRSH offers elite cardiology teams. Patients with multiple comorbidities should seek multidisciplinary geriatric assessments available at Hainan Chengmei Hospital. For specialized thrombosis-related arrhythmia, Xiamen Humanity Hospital provides expert biomarker testing and emergency care led by postdoctoral specialists. International patients find better value at these large-scale academic centers due to high surgical volumes.
| China | Turkey | Austria | |
| Radiofrequency ablation with 3D mapping | from $8,500 | ≈ $4,800 | ≈ $9,500 |
| Radiofrequency ablation | ≈ $6,500 | from $5,500 | ≈ $7,500 |
| Heart cryoablation | ≈ $19,500 | from $5,900 | ≈ $14,500 |
No hidden fees – just official clinic prices. Pay at the clinic for Arrhythmia treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Arrhythmia treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Arrhythmia treatment journey.
Dr. Xu Juntang, MD, is a Postdoctoral Fellow, Chief Physician, and Master’s Supervisor. He is the Director of Cardiovascular Medicine at Xiamen Humanity Hospital. His work focuses on preventing and treating cardiovascular and thrombotic diseases, including coronary artery disease, hypertension, heart failure, arrhythmias, and emergencies. He is skilled in cardiovascular biomarker testing.
He provides standardized care for thromboembolism related to valvular heart disease and non‑valvular atrial fibrillation, pulmonary embolism, deep vein thrombosis, and obstetric thrombophilia. He also conducts clinical and laboratory assessments of thrombosis and coagulation disorders. He is the Vice Chairman of the Laboratory and Clinical Branch of the Chinese Society of Cardiothoracic and Vascular Anesthesiology.